First experiences with (177)Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer

BACKGROUND: Advanced salivary gland cancers become difficult to treat when they are technically irresectable and radiotherapy limits are exceeded. There is also an unmet need to improve palliative systemic therapy. Salivary glands depict the Prostate-Specific Membrane Antigen (PSMA) on (68)Ga-PSMA-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein Nulent, Thomas J. W., van Es, Robert J. J., Willems, Stefan M., Braat, Arthur. J. A. T., Devriese, Lot A., de Bree, Remco, de Keizer, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671577/
https://www.ncbi.nlm.nih.gov/pubmed/34905121
http://dx.doi.org/10.1186/s13550-021-00866-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671577/
https://www.ncbi.nlm.nih.gov/pubmed/34905121
http://dx.doi.org/10.1186/s13550-021-00866-8

Ejemplares similares